# A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B

> **NCT07555340** · — · ACTIVE_NOT_RECRUITING · sponsor: **Juan Li** · enrollment: 400 (estimated)

## Conditions studied

- HEPATITIS B CHRONIC

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07555340
- **Lead sponsor:** Juan Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-12-30
- **Primary completion:** 2026-05
- **Final completion:** 2028-06
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07555340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07555340, "A Real-World Study on the Efficacy and Safety of Pradefovir Mesylate Tablets in the Treatment of Chronic Hepatitis B". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07555340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*